Noetic Fund
Noetic invests in early-stage technologies addressing mental health and wellbeing through novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables and evidence-backed solutions targeting root causes with focus on early intervention and prevention.
Check Size—
StagesSeed, Early stage
LocationNorth America
Data quality70good
Investment thesis
Noetic invests in early-stage technologies addressing mental health and wellbeing through novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables and evidence-backed solutions targeting root causes with focus on early intervention and prevention.
90 confidence · stated by fund
What sets Noetic Fund apart
- Deep scientific expertise with Ph.D. scientific lead (Sri Teja Mullapudi) and pharma counsel (Richard Cheung)
- First-mover advantage in psychedelic therapeutics investment thesis (pre-FDA approval expansion)
- Global outlook spanning US, Canada, Europe
- Real-world evidence infrastructure (Victor Mifsud, Head of RWE)
Investment profile
- Stages
- Seed, Early stage
- Sectors
- Biotech, Pharmaceuticals, Psychedelics, Digital health, Wellness
- Cold inbound
- Warm intro preferred
Frequently asked questions
- What does Noetic Fund invest in?
- Noetic Fund is a seed, early stage stage Biotech, Pharmaceuticals, Psychedelics, Digital health, Wellness investor, primarily investing in North America. Their thesis: Noetic invests in early-stage technologies addressing mental health and wellbeing through novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables and evidence-backed solutions targeting root causes with focus on early intervention and prevention.
- Is Noetic Fund actively deploying capital?
- Noetic Fund is actively deploying capital. What we observed: Fund II portfolio listed with active companies; no final close date mentioned suggesting ongoing deployment
- What makes Noetic Fund different from other funds?
- Noetic Fund stands out on 4 points: Deep scientific expertise with Ph.D. scientific lead (Sri Teja Mullapudi) and pharma counsel (Richard Cheung); First-mover advantage in psychedelic therapeutics investment thesis (pre-FDA approval expansion); Global outlook spanning US, Canada, Europe; Real-world evidence infrastructure (Victor Mifsud, Head of RWE).
- What other funds are similar to Noetic Fund?
- Funds with overlapping stage and sector focus include AME Cloud Ventures. See the full list below, or use DryPowder's AI fund matching to rank all tracked funds by fit with your specific startup.
- How do I reach out to Noetic Fund?
- Noetic Fund doesn't generally take cold inbound — a warm introduction from a founder or investor they already know is the reliable path in. Use DryPowder's AI fund matching to see how your startup aligns with Noetic Fund's thesis and focus areas (Biotech, Pharmaceuticals, Psychedelics, Digital health, Wellness) — it returns a fit score and specific talking points for your outreach.